Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A new immunotherapy ROR: Proximal ROR1 domain targeting breast cancer via monoclonal antibodies and CAR NK cells. | Mol Ther | 2026 | 41720103 | PubTator, text mining | PubMed |
| Deep immune-phenotyping of HLA-homozygous iPS-cardiomyocytes by spectral flow cytometry. | Front Immunol | 2026 | 41716415 | PubTator, text mining | PubMed |
| Human Endometriotic Lesion-Derived Small Extracellular Vesicles Impair Macrophage Function in the Peritoneal Microenvironment. | J Extracell Vesicles | 2026 | 41711665 | PubTator, text mining | PubMed |
| CAR-T cell immunotherapy in rhabdomyosarcoma. | J Transl Med | 2026 | 41709231 | PubTator, text mining | PubMed |
| One-Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand-Directed Acylation Strategy. | ChemMedChem | 2026 | 41678356 | PubTator, text mining | PubMed |
| Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts. | Mol Ther Oncol | 2026 | 41659920 | PubTator, text mining | PubMed |
| Multi-platform integration of brain and CSF proteomes reveals biomarker panels for Alzheimer's disease. | Brief Bioinform | 2026 | 41608987 | PubTator, text mining | PubMed |
| Metformin-Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention. | Cancer Med | 2026 | 41603225 | PubTator, text mining | PubMed |
| In vivo engineering of CAR-T cells: delivery strategies and clinical translation. | Biomark Res | 2026 | 41593732 | PubTator, text mining | PubMed |
| In vitro investigation of miR-206-3p-loaded extracellular vesicles as modulators of Aβ-induced neurodegeneration. | Biochem Biophys Res Commun | 2026 | 41592400 | PubTator, text mining | PubMed |
| Dual targeting of CD155 augments the antitumor efficacy of ROR1-CAR-T cells in ovarian cancer. | Cancer Immunol Immunother | 2026 | 41591545 | PubTator, text mining | PubMed |
| Universal Antibody-Engineered Lipid Nanoparticles Potentiate Chemo-Immunotherapy Against Triple-Negative Breast Cancer by Reprogramming Tumor Cell Metabolism. | Adv Sci (Weinh) | 2026 | 41591256 | PubTator, text mining | PubMed |
| Targeting WTAP/ROR1/WNT5A-Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy. | Adv Sci (Weinh) | 2026 | 41562250 | PubTator, text mining | PubMed |
| <p>Tumor microenvironment in bone sarcomas: Implications for immunotherapy and emerging therapeutic vulnerabilities (Review)</p>. | Oncol Rep | 2026 | 41543186 | PubTator, text mining | PubMed |
| The making of multispecific immunoglobulins - a clinical perspective. | MAbs | 2026 | 41542910 | PubTator, text mining | PubMed |
| Metabolic adaptations rewire CD4+ T cells in a subset-specific manner in human critical illness with and without sepsis. | Nat Immunol | 2026 | 41540263 | PubTator, text mining | PubMed |
| Cholesterol Deficiency Directs Autophagy-Dependent Secretion of Extracellular Vesicles. | J Extracell Vesicles | 2026 | 41538718 | PubTator, text mining | PubMed |
| Cell therapy in sarcoma: current landscape and future directions. | J Immunother Cancer | 2026 | 41526168 | PubTator, text mining | PubMed |
| CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management. | Transl Oncol | 2026 | 41496418 | PubTator, text mining | PubMed |
| ROR1 protein: a pseudokinase at the crossroads of cancer progression and therapy. | Mol Biol Rep | 2026 | 41493647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=3